HIGHLIGHTS
- who: Benjamin Mordmüller from the Trial participants We recruited healthy, malaria-naïve volunteers, aged, years at the clinical trial facility of the Institute of Tropical Medicine, Tübingen University Hospital, GermanyFollowing written informed consent, volunteers underwent medical and laboratory examinations to minimize Published in partnership with the Sealy Institute for Vaccine Sciences have published the article: A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection, in the Journal: (JOURNAL)
- what: The authors report two major contributions to development of PfSPZ Vaccine for prevention of Pf malaria.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.